Teriparatide Increases Strength of the Peripheral Skeleton in Premenopausal Women With Idiopathic Osteoporosis: A Pilot HR-pQCT Study
Author(s) -
Kyle K. Nishiyama,
Adi Cohen,
Polly Young,
Ji Wang,
Joan M. Lappe,
X. Edward Guo,
David W. Dempster,
Robert R. Recker,
Elizabeth Shane
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-1041
Subject(s) - quantitative computed tomography , osteoporosis , medicine , bone mineral , tibia , teriparatide , trabecula (gastropod) , cortical bone , bone density , peripheral , anatomy , botany , biology , genus
In premenopausal women with idiopathic osteoporosis (IOP), treatment with teriparatide leads to substantial improvement in bone density and quality at central skeletal sites. The effects of teriparatide may differ on cortical and trabecular bone and also at the central and the peripheral skeleton.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom